Nuclear Imaging

Molecular Imaging

Nuclear Imaging

Discovery NM/CT 670 Pro, SPECT/CT

GE Healthcare introduced the Discovery NM/CT 670 Pro at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). Quantitative accuracy in nuclear medicine is enabled by Q.Metrix and Q.AC, GE Healthcare's newest software i...

September 24, 2014 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery IQ PET/CT (positron emission tomography/computed tomography) system.

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging techni...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

University of Tubingen and Mediso Ltd announced at the 4th Tubingen PET/MR Workshop a collaboration to develop a whole body preclinical positron emission...
PET/CT, lung cancer, follow-up, tumor tracking, nuclear imaging, trial
New research from Johns Hopkins School of Medicine reveals a high value for scans which could lead to future change of reimbursement policies for follow-up...
Alzheimer's, tau PET tracers, positron emission tomography, dementia, research
One of the hottest topics in current Alzheimer’s research is brain scans that visualize tau pathology in living people. With the advent of positron emission...
holmium beads, radiation therapy, UMC Utrecht, radiopharmaceuticals, tracers
Researchers at University Medical Center (UMC) Utrecht are developing an innovative cancer treatment involving the injection of radioactive beads into...
Siemens Healthcare's Symbia Evo Excel SPECT (single-photon emission computed tomography) system, a new version of the company’s Symbia E
Navidea Biopharmaceuticals' Inc. Lymphoseek (technetium Tc 99m tilmanocept) injection is U.S. Food and Drug Administration (FDA)-...
501(k)-cleared by the U.S. Food and Drug Administration (FDA), GE Healthcare's Discovery IQ PET/CT (positron emission tomography/computed...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the...

Articles

A new breast imaging technique pioneered at Mayo Clinic nearly quadruples detection rates of invasive breast cancers in women with dense breast tissue,...
The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based imaging agent jointly developed at Washington...
Physicians at Northwestern Memorial Hospital in Chicago were as stunned in 1979 by Godfrey Hounsfield’s exclamation as Hounsfield was at the computed...
Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...

Video Center

It’s been no secret that the American healthcare system needed to change to survive economically...
2 weeks 4 days ago
In 1934, a Senate committee opened hearings its chairman said would show that America’s involvement...
3 weeks 4 days ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
4 weeks 4 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
The webinar "Any Image, Anywhere" explains the new ways radiologists and clinicians can boost productivity, optimize scarce resources, and connect their...